Research Keyword: cryptococcal antigen screening

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

This survey asked infectious disease doctors across the United States about their use of a simple blood test (cryptococcal antigen screening) for HIV patients. The test can detect a dangerous fungal infection weeks before symptoms appear, allowing for early treatment. However, the survey found that many doctors are not using this recommended test regularly, primarily because they are unsure about its benefits and are confused about screening guidelines.

Read More »

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States about how often they screen HIV patients for cryptococcal infections using a simple blood test. They found that only about one-third to two-thirds of doctors regularly perform this screening despite guidelines recommending it. Many doctors expressed uncertainty about whether the screening is beneficial or weren’t sure about the official recommendations, suggesting a need for better education about this potentially life-saving test.

Read More »

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States to understand how often they test HIV patients for cryptococcal antigen, a fungal infection that can be serious. The study found that doctors don’t consistently follow recommended screening guidelines, with many uncertain about the benefits of testing. Key barriers included confusion about testing recommendations and concerns about delaying HIV treatment, suggesting that doctors need better education about the importance of early detection.

Read More »
Scroll to Top